Live News • Jun 05
Neurones Shareholders Approve New €90 Buyback Program Covering Up To 10% Of Capital The shareholders’ meeting on 4 June 2026 renewed authorization for the Board to repurchase Neurones shares for an 18‑month period.
The program allows buybacks of up to 10% of the share capital at a maximum price of €90 per share.
Potential uses include share cancellation, liquidity support, employee share plans and using shares as consideration in external growth transactions.
This renewed buyback authorization gives the Board flexibility to adjust capital allocation, manage the share count and support trading liquidity if it chooses to use the program.
You should watch how actively the authorization is used, since actual buybacks, cancellations or share-based deal activity could affect per-share metrics and ownership dilution over time. Upcoming Dividend • Jun 03
Upcoming dividend of €1.40 per share Eligible shareholders must have bought the stock before 10 June 2026. Payment date: 12 June 2026. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 3.7%. Lower than top quartile of French dividend payers (5.5%). Higher than average of industry peers (3.2%). Declared Dividend • Apr 29
Dividend increased to €1.40 Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Announcement • Apr 28
Neurones S.A., Annual General Meeting, Jun 04, 2026 Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre France Buy Or Sell Opportunity • Mar 20
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 21% to €34.00. The fair value is estimated to be €42.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period. Reported Earnings • Mar 12
Full year 2025 earnings released Full year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the IT industry in France. Announcement • Nov 08
Neurones S.A. Provides Earnings Guidance for the Full Year 2025 Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% . Announcement • Nov 05
Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026 Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026 Buy Or Sell Opportunity • Sep 26
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 15% to €38.80. The fair value is estimated to be €48.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period. Reported Earnings • Sep 12
First half 2025 earnings released First half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the IT industry in France. Price Target Changed • Aug 07
Price target decreased by 13% to €52.00 Down from €60.00, the current price target is provided by 1 analyst. New target price is 25% above last closing price of €41.65. Stock is down 1.5% over the past year. The company is forecast to post earnings per share of €1.99 for next year compared to €2.17 last year. Upcoming Dividend • Jun 04
Upcoming dividend of €1.30 per share Eligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (5.5%). Higher than average of industry peers (2.3%). Declared Dividend • May 02
Dividend increased to €1.30 Dividend of €1.30 is 8.3% higher than last year. Ex-date: 11th June 2025 Payment date: 13th June 2025 Dividend yield will be 2.7%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 36% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 11% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Announcement • Apr 29
Neurones S.A., Annual General Meeting, Jun 05, 2025 Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France Reported Earnings • Mar 09
Full year 2024 earnings released Full year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses. Announcement • Mar 06
Neurones S.A. Proposes Dividend for 2024 Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year). Price Target Changed • Feb 13
Price target increased by 13% to €54.00 Up from €48.00, the current price target is provided by 1 analyst. New target price is 14% above last closing price of €47.40. Stock is up 7.7% over the past year. The company is forecast to post earnings per share of €2.05 for next year compared to €2.04 last year. Buy Or Sell Opportunity • Aug 03
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to €40.75. The fair value is estimated to be €51.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year. Upcoming Dividend • Jun 05
Upcoming dividend of €1.20 per share Eligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of French dividend payers (5.1%). Higher than average of industry peers (1.8%). Announcement • May 17
Neurones S.A. Provides Earnings Guidance for the Year 2024 Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%. Declared Dividend • May 03
Dividend of €1.20 announced Shareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 1.6%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend. Buy Or Sell Opportunity • Apr 11
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 9.7% to €46.95. The fair value is estimated to be €38.99, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year. Reported Earnings • Mar 08
Full year 2023 earnings released Full year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue. Announcement • Nov 10
Neurones S.A. Provides Earnings Guidance for the Year 2023 Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%. Buying Opportunity • Oct 09
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 7.3%. The fair value is estimated to be €46.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years. Buying Opportunity • Sep 14
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be €45.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 20% in the next 2 years. Reported Earnings • Sep 08
First half 2023 earnings released First half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the IT industry in France. Announcement • Sep 07
Neurones S.A. Provides Earnings Guidance for the Full Year 2023 Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%. Upcoming Dividend • Jun 07
Upcoming dividend of €1.10 per share at 2.8% yield Eligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (1.9%). Announcement • May 11
Neurones S.A. Provides Earnings Guidance for the Full Year 2023 Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%. Reported Earnings • Mar 12
Full year 2022 earnings released Full year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 7.3% growth forecast for the IT industry in France. Announcement • Feb 09
Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023 Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023 Price Target Changed • Dec 08
Price target increased to €44.33 Up from €41.00, the current price target is an average from 3 analysts. New target price is 15% above last closing price of €38.50. Stock is up 11% over the past year. The company is forecast to post earnings per share of €1.89 for next year compared to €1.56 last year. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Nov 12
Neurones S.A., Annual General Meeting, Jun 08, 2023 Neurones S.A., Annual General Meeting, Jun 08, 2023. Announcement • Nov 11
Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023 Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023 Announcement • Sep 10
Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022 Neurones S.A. confirmed its earnings guidance for the full year 2022. For the year, the company expects revenues of at least €640 million and an operating profit of around 10.5%. Reported Earnings • Sep 09
First half 2022 earnings released First half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the IT industry in France. Announcement • Aug 04
Neurones S.A. Provides Earnings Guidance for the Year 2022 Neurones S.A. provided earnings guidance for the year 2022. The company expects revenues of at least €640 million (vs. €625 million previously forecast), An operating profit of around 10.5% (vs > 10%). Upcoming Dividend • Jun 01
Upcoming dividend of €1.00 per share Eligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of French dividend payers (4.9%). Higher than average of industry peers (1.6%). Reported Earnings • Apr 27
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 12% growth forecast for the industry in France. Price Target Changed • Apr 27
Price target increased to €41.00 Up from €37.50, the current price target is an average from 3 analysts. New target price is 17% above last closing price of €35.10. Stock is up 25% over the past year. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Mar 11
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 11% growth forecast for the industry in France. Upcoming Dividend • Jun 02
Upcoming dividend of €2.00 per share Eligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of French dividend payers (3.8%). Lower than average of industry peers (1.4%). Price Target Changed • May 12
Price target increased to €32.50 Up from €30.00, the current price target is an average from 2 analysts. New target price is 18% above last closing price of €27.60. Stock is up 36% over the past year. Price Target Changed • May 06
Price target increased to €31.00 Up from €28.25, the current price target is an average from 2 analysts. New target price is 8.0% above last closing price of €28.70. Stock is up 47% over the past year. Reported Earnings • May 02
Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019) The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 2% per year. Reported Earnings • Mar 06
Full year 2020 earnings released The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Analyst Estimate Surprise Post Earnings • Mar 06
Revenue beats expectations Revenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 33% growth forecast for the IT industry in France. Is New 90 Day High Low • Feb 12
New 90-day high: €25.70 The company is up 9.0% from its price of €23.50 on 13 November 2020. The French market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.84 per share. Price Target Changed • Feb 12
Price target raised to €29.00 Up from €27.00, the current price target is an average from 2 analysts. The new target price is 13% above the current share price of €25.70. As of last close, the stock is up 12% over the past year. Price Target Changed • Jan 14
Price target raised to €28.25 Up from €26.00, the current price target is an average from 2 analysts. The new target price is 21% above the current share price of €23.40. As of last close, the stock is up 14% over the past year. Is New 90 Day High Low • Dec 24
New 90-day low: €23.00 The company is down 3.0% from its price of €23.60 on 24 September 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €18.98 per share. Major Estimate Revision • Nov 07
Analysts increase EPS estimates to €1.12 The 2020 consensus revenue estimate increased from €499.7m to €512.6m. The earnings per share estimate also received an upgrade from €1.00 to €1.12 for the same period. Net income is expected to shrink by 1.2% next year compared to 0.8% growth forecast for the IT industry in France . The consensus price target increased from €26.00 to €27.00. Share price is up 2.1% to €23.90 over the past week.